- Telehealth Visits
- Insurance plan information
Qi Quan Leong, MD
He | Him | HisInfectious Diseases- Telehealth Visits
- Insurance plan information
Qi Quan Leong, MD
He | Him | HisInfectious Diseases- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Qi Quan Leong is a specialist in infectious diseases who cares for patients in both the hospital and the clinic. With a special focus on caring for patients living with HIV, he oversees a program providing injectable PrEP (pre-exposure prophylaxis) and ART (antiretroviral therapy). He is also involved in antimicrobial stewardship (managing antibiotic use to prevent germs from developing drug resistance) and infection control strategies in the hospital.
Leong earned his medical degree at Sidney Kimmel Medical College (formerly Jefferson Medical College). He completed a residency in internal medicine at York Hospital, followed by a fellowship in infectious diseases at Westchester Medical Center.
This provider works with UCSF through the UCSF Health Community Medical Group, a multispecialty group connecting doctors and practices throughout the Bay Area.
Education & training
Board certification
- Infectious Disease, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Infectious Diseases, Westchester Medical Center - GME
Residency
- Internal Medicine, York Hospital GME
Degree
- MD, Thomas Jefferson University Medical College
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224753%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224753%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.